Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2025-12-24 @ 3:52 PM
NCT ID:
NCT01797692
Eligibility Criteria:
Inclusion Criteria for patients:
* Patients aged 75 years or more
* Patients with a personal history of prostate cancer with a diagnosis ≥ 10 years
* Patients who received curative treatment (surgery, radiotherapy,hormone therapy, brachytherapy, technical ablative) for localized prostate cancer
* Patients considered cured of prostate cancer (regardless of initial treatment)
* Patients with previously agreed to participate in a case-control study in the general population (study QALIPRO) as a case and volunteer to receive an assessment of geriatric
* Signature of consent
* Affiliation to a social security system
Exclusion Criteria for patients:
* Patients under 75 years
* Patients with recurrent or metastatic
* Persons deprived of liberty or under guardianship
Inclusion Criteria for control population:
* Male subjects
* Subjects of 75 years or more
* Subjects that do not have cancer or a history of cancer (except basal cell skin cancer)
* Subject has previously agreed to participate in a case-control study in the general population (study QALIPRO) as a voluntary witness and to benefit from a balance oncogeriatrics
* Subjects who gave their written consent to participate in the study
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
75 Years
Study:
NCT01797692
Study Brief:
Protocol Section:
NCT01797692